Canaccord Genuity’s 45th Annual Growth Conference
Logotype for Edgewell Personal Care Company

Edgewell Personal Care Company (EPC) Canaccord Genuity’s 45th Annual Growth Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Edgewell Personal Care Company

Canaccord Genuity’s 45th Annual Growth Conference summary

3 Feb, 2026

Transformation progress and business strengths

  • International business drives 40% of revenue, growing 4-5% annually, with strong brands and local innovation focus.

  • Productivity savings are embedded, delivering 250-300 basis points annually, supporting future margin expansion.

  • Free cash flow averages $150M-$180M, with a low CapEx profile and strong profit conversion.

  • U.S. business undergoing transformation with new leadership, strategic review, and commercial reorganization.

  • Innovation structure replatformed, with successful new product launches in international markets.

Financial outlook and performance

  • Long-term top-line growth target remains 2-3%, with international outpacing U.S. growth.

  • Q3 was challenging due to weak sun care season, but productivity savings and international share gains were highlights.

  • Q4 expected to show organic growth of 2-2.5%, with 8% growth in international and sequential improvement in North America.

  • Gross margin expansion is a focus, with 2025 impacted by tariffs, currency, and mix, but long-term levers remain strong.

  • Free cash flow for 2025 estimated at $80M due to transitory headwinds, but long-term range of $150M-$200M expected.

Tariffs, pricing, and capital allocation

  • Tariff exposure estimated at $40M-$50M annually (3-4% of COGS), with mitigation through cost and pricing actions.

  • Pricing already initiated in international markets; U.S. to follow market leaders.

  • Capital allocation has prioritized debt paydown and share repurchases; near-term focus likely on reducing leverage.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more